Techniclone (TCLN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Techniclone (TCLN)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Terry D. who wrote (3591)	7/8/2000 7:41:34 PM
From: EZLibra	Read Replies (1) of 3702

Your R & D on the dd surpasses par excellence, as usual Terry. Thanx. I tried to talk about the potential impact of our VTA technology on SI over two years ago but was shushed by a call from Tustin. The key enabling patent to the whole shebang wasn't issued until January this year and at the time they were wary of a possible interference proceeding. IMO Techniclone's VTA platform is bigger than all the Entremed's rolled together. Again in March I was gushing over VTA (SI March 10..."VTA licensing is just beginning and I fully expect 40-60 licenses over the next year or so.") I'm glad to see fellow elegant science/downtrodden biotech CYTO is in license negotiations as well as the three Big Pharma. When the first Major licenses the VTA technology I predict they all will, or face the consequences (you hear that Imclone?). Looks to me like BMY is coming at us through the OxiGene JV and JB himself. Thanks again for the dd, Terry, but I think you will be even busier. I think a proper trail on the TCLN VTA technology is likely to spread across the entire cancer therapeutics spectrum. Cotara anyone?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next